循环性肿瘤细胞市场规模、份额及成长分析（依技术、应用、产品、检体、最终用途及地区）－2025-2032 年产业预测

2023 年全球循环性肿瘤细胞市场规模价值 122 亿美元，预计将从 2024 年的 135.5 亿美元成长到 2032 年的 314.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 11.1%。

由于癌症诊断技术的创新和癌症发生率的上升，全球循环性肿瘤细胞(CTC) 市场正在经历动态成长。对非侵入性诊断工具（尤其是 CTC 分析）的需求受到个人化医疗的转变和早期癌症检测的迫切需求的推动。然而，技术复杂性和缺乏标准化等挑战阻碍了其更广泛的应用。目前以ELISA和PCR方法是主流产品。北美凭藉其强大的医疗保健基础设施占据了很大的市场占有率。该市场的特点是持续的研究倡议、合作和创新产品开发，旨在应对不断变化的医疗保健格局并改善患者的治疗效果。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

循环性肿瘤细胞市场规模（依技术及复合年增长率） (2025-2032)

• 市场概览
• CTC检测和富集方法
  • 免疫捕获（基于标记）
  • 正向选择
  • 负面选择
  • 尺寸分离（无标定）
  • 基于膜
  • 基于微流体
  • 基于密度的分离（无标定）
  • 组合法
• 直接CTC检测方法
  • SERS
  • 显微镜
  • 其他的
• CTC分析

循环性肿瘤细胞市场规模（依应用）及复合年增长率（2025-2032）

• 市场概览
• 临床/液态生物检体
  • 风险评估
  • 筛检和监测
• 调查
  • 研究癌症干细胞和肿瘤发生
  • 药物和治疗方法开发

循环性肿瘤细胞市场规模（按产品和复合年增长率） (2025-2032)

• 市场概览
• 套件和试剂
• 采血管
• 设备或系统

循环性肿瘤细胞市场规模（检体和复合年增长率） (2025-2032)

• 市场概览
• 血
• 骨髓
• 其他体液

循环性肿瘤细胞市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概览
• 研究和学术机构
• 医院和诊所
• 诊断中心

循环性肿瘤细胞市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
• 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Sysmex Corporation（Japan）
• Bio-Techne Corporation（USA）
• Thermo Fisher Scientific Inc.（USA）
• Miltenyi Biotec GmbH（Germany）
• Biolidics Limited（Singapore）
• ScreenCell（France）
• Greiner Bio-One International GmbH（Austria）
• AVIVA Biosciences（USA）
• BIOCEPT, Inc.（USA）
• Ikonisys, Inc.（USA）
• Epic Sciences（USA）
• Rarecells Diagnostics（France）
• STEMCELL Technologies, Inc.（Canada）
• Precision for Medicine（USA）
• ANGLE plc（UK）
• Creatv MicroTech, Inc.（USA）

结论和建议

Global Circulating Tumor Cell Market size was valued at USD 12.2 billion in 2023 and is poised to grow from USD 13.55 billion in 2024 to USD 31.46 billion by 2032, growing at a CAGR of 11.1% during the forecast period (2025-2032).

The global Circulating Tumor Cell (CTC) market is witnessing dynamic growth, driven by innovations in cancer diagnostics and an increasing incidence of cancer. The demand for non-invasive diagnostic tools, particularly CTC analysis, is fueled by a shift towards personalized medicine and a pressing need for early cancer detection. However, challenges such as technological complexities and the lack of standardization hinder broader adoption. Currently, ELISA and PCR-based methods dominate the product landscape. North America commands a significant market share attributed to its robust healthcare infrastructure. The market is characterized by continuous research initiatives, collaborative efforts, and innovative product developments aimed at addressing the evolving medical landscape and enhancing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Circulating Tumor Cell market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Circulating Tumor Cell Market Segments Analysis

Global Circulating Tumor Cell Market is segmented by Technology, Application, Product, Specimen, End Use and region. Based on Technology, the market is segmented into CTC detection & enrichment methods, CTC Direct Detection Methods and CTC Analysis. Based on Application, the market is segmented into Clinical/ Liquid Biopsy and Research. Based on Product, the market is segmented into Kits & Reagents, Blood Collection Tubes and Devices or Systems. Based on specimen, the market is segmented into Blood, Bone Marrow and Other Body Fluids. Based on End Use, the market is segmented into Research and academic institutes, Hospital and clinics and Diagnostic centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Circulating Tumor Cell Market

The rising incidence of cancer worldwide has intensified the demand for advanced diagnostic tools, with circulating tumor cell (CTC) analysis gaining prominence as a non-invasive and valuable technique for cancer detection and monitoring. Additionally, the focus on personalized medicine and the urgency for early cancer diagnosis are driving the adoption of CTC technologies. This growing need for effective diagnostic solutions is reshaping the global landscape of cancer management and treatment, fostering innovation and advancements in the CTC market, which aims to provide better outcomes for patients through improved detection and monitoring capabilities.

Restraints in the Global Circulating Tumor Cell Market

One of the primary challenges facing the global circulating tumor cell (CTC) market is the technological complexity involved in CTC analysis. This intricacy complicates the process and highlights the need for standardization across various methodologies, which hinders widespread acceptance and implementation. Furthermore, concerns regarding the reliability and reproducibility of CTC results create additional barriers, making it difficult for these techniques to be integrated into standard clinical practices. As such, these factors collectively contribute to limiting the overall growth and adoption of CTC technologies in the healthcare sector, restraining market potential.

Market Trends of the Global Circulating Tumor Cell Market

The global circulating tumor cell (CTC) market is witnessing a significant trend characterized by the increasing integration of CTC analysis into routine clinical practice. This shift is driven by the technology's ability to facilitate real-time cancer progression tracking and treatment response evaluation. Advances in innovative technologies such as microfluidic systems and sophisticated molecular detection techniques are enhancing the precision and sensitivity of CTC analysis. Additionally, the rising awareness and adoption of liquid biopsy methods for cancer diagnostics underscore the critical role of CTCs as valuable biomarkers. This convergence of technology and clinical application is poised to revolutionize cancer care and diagnosis.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Circulating Tumor Cell Market Size by Technology & CAGR (2025-2032)

• Market Overview
• CTC detection & enrichment methods
  • Immunocapture (label-based)
  • Positive selection
  • Negative selection
  • Size-based separation (label-free)
  • Membrane-based
  • Microfluidic-based
  • Density-based separation (label-free)
  • Combined methods
• CTC Direct Detection Methods
  • SERS
  • Microscopy
  • Others
• CTC Analysis

Global Circulating Tumor Cell Market Size by Application & CAGR (2025-2032)

• Market Overview
• Clinical/ Liquid Biopsy
  • Risk Assessment
  • Screening and Monitoring
• Research
  • Cancer stem cell & tumorogenesis research
  • Drug/therapy development

Global Circulating Tumor Cell Market Size by Product & CAGR (2025-2032)

• Market Overview
• Kits & Reagents
• Blood Collection Tubes
• Devices or Systems
• Global Circulating Tumor Cell Market Size by Specimen & CAGR (2025-2032)
• Market Overview
• Blood
• Bone Marrow
• Other Body Fluids

Global Circulating Tumor Cell Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Research and academic institutes
• Hospital and clinics
• Diagnostic centers

Global Circulating Tumor Cell Market Size & CAGR (2025-2032)

• North America (Technology, Application, Product, Specimen, End Use)
  • US
  • Canada
• Europe (Technology, Application, Product, Specimen, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Application, Product, Specimen, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Application, Product, Specimen, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Application, Product, Specimen, End Use)
  • GCC Countries
• South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biolidics Limited (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScreenCell (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Greiner Bio-One International GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AVIVA Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOCEPT, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ikonisys, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rarecells Diagnostics (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision for Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANGLE plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creatv MicroTech, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations